Gene · 57733
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis. | Int J Gen Med | 2022 | 35431572 | PubTator, text mining | PubMed |
| Proteomic Analysis of Methylglyoxal Modifications Reveals Susceptibility of Glycolytic Enzymes to Dicarbonyl Stress. | Int J Mol Sci | 2022 | 35409048 | PubTator, text mining | PubMed |
| Polyphenols and Their Metabolites in Renal Diseases: An Overview. | Foods | 2022 | 35407148 | PubTator, text mining | PubMed |
| Deciphering Genetic Susceptibility to Tuberculous Meningitis. | Front Neurol | 2022 | 35401413 | PubTator, text mining | PubMed |
| Glyco-Decipher enables glycan database-independent peptide matching and in-depth characterization of site-specific N-glycosylation. | Nat Commun | 2022 | 35393418 | PubTator, text mining | PubMed |
| Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression? | Front Immunol | 2022 | 35371018 | PubTator, text mining | PubMed |
| Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43. | Nature | 2022 | 35344984 | PubTator, text mining | PubMed |
| Novel missense ACAN gene variants linked to familial osteochondritis dissecans cluster in the C-terminal globular domain of aggrecan. | Sci Rep | 2022 | 35338222 | PubTator, text mining | PubMed |
| Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy. | Pharmaceutics | 2022 | 35335891 | PubTator, text mining | PubMed |
| Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside. | Nutrients | 2022 | 35334812 | PubTator, text mining | PubMed |
| Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors. | Nat Commun | 2022 | 35332119 | PubTator, text mining | PubMed |
| Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway. | Life (Basel) | 2022 | 35330102 | PubTator, text mining | PubMed |
| Complex of HIV-1 Integrase with Cellular Ku Protein: Interaction Interface and Search for Inhibitors. | Int J Mol Sci | 2022 | 35328329 | PubTator, text mining | PubMed |
| Method for Identifying Galectin Ligands on Lymphocyte Membrane Glycoproteins. | Methods Mol Biol | 2022 | 35320529 | PubTator, text mining | PubMed |
| PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial. | Nat Med | 2022 | 35314843 | PubTator, text mining | PubMed |
| Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice. | PLoS One | 2022 | 35312707 | PubTator, text mining | PubMed |
| The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta. | J Biol Chem | 2022 | 35304099 | PubTator, text mining | PubMed |
| ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers. | Sci Adv | 2022 | 35302851 | PubTator, text mining | PubMed |
| Short open reading frames (sORFs) and microproteins: an update on their identification and validation measures. | J Biomed Sci | 2022 | 35300685 | PubTator, text mining | PubMed |
| Miniaturization of Bright Light-Emitting Luciferase ALuc: picALuc. | ACS Chem Biol | 2022 | 35293729 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57733/papers?page=19